Netskope's consensus price target has decreased, yet some analysts see significant upside potential. The company reports 33% revenue growth and a 118% net retention rate, indicating strong customer r

Bank of America Securities Maintains "Buy" Rating for BioNTech (NASDAQ:BNTX) Bank of America Securities maintained its “Buy” rating for BioNTech (NASDAQ:BNTX) while lowering its price tar

Morgan Stanley sets a price target of $117 for NYSE:PLNT, indicating a potential upside of 52.19%. Tom Fitzgerald steps in as Interim CFO following Jay Stasz's departure, with the company actively se

Ultralife Corporation (NASDAQ:ULBI) reported an EPS of -$0.45, missing the estimated $0.24 due to an intangible asset impairment charge. The company's revenue was $48.5 million, below the forecasted

Leerink Partners sets a price target of $119 for Medtronic, Inc. (NYSE:MDT), indicating a potential upside of 31.78%. Medtronic acquires Scientia Vascular for $550 million to enhance its Neurovascula

On March 9, 2026, Pete Sessions, a representative from Texas's 17th district, sold shares of Verizon Communications Inc. (NYSE:VZ). The transaction was valued between $1,001 and $15,000. Verizon is a